CDC25A anticorps (AA 190-484)
Aperçu rapide pour CDC25A anticorps (AA 190-484) (ABIN5027104)
Antigène
Voir toutes CDC25A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 190-484
-
Purification
- Protein G Chromatography
-
Immunogène
- A partial length recombinant CDC25A protein (amino acids 190-484) was used as the immunogen for this antibody.
-
Isotype
- IgG2b kappa
-
-
-
-
Indications d'application
- WB: 2-4 μg/mL, IHC: 5 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS containing 0.05 % BSA, PH 7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeated freeze and thaw cycles.
-
-
- CDC25A (Cell Division Cycle 25 Homolog A (S. Pombe) (CDC25A))
-
Autre désignation
- CDC25A
-
Sujet
- CDC25A is a dual specificity (tyr/thr) phosphatase and a putative upregulated c-Myc target gene. It is a regulator of the cell cycle required for progression from G1 to S phase. CDC25A is a member of the CDC25 family of phosphatases. CDC25A is specifically degraded in response to DNA damage, which prevents cells with chromosomal abnormalities from progressing through cell division. Overexpression of CDC25A bypassed the mechanism of cell cycle arrest, leading to enhanced DNA damage and decreased cell survival. Specific degradation of CDC25A is identified as part of the DNA damage checkpoint mechanism and suggested how CDC25A overexpression in human cancers might contribute to tumorigenesis.
-
Poids moléculaire
- 59 kDa
-
ID gène
- 993
-
UniProt
- P30304
-
Pathways
- Cycle Cellulaire, Mitotic G1-G1/S Phases, M Phase
Antigène
-